Literature DB >> 7834255

Continuation ECT: relapse prevention in affective disorders.

G Petrides1, D Dhossche, M Fink, A Francis.   

Abstract

Relapse rates after the acute treatment of affective disorders with drugs or electroconvulsive therapy (ECT) are high (often 50-95%), despite preventive pharmacotherapy. In practice, some patients receive continuation and maintenance ECT after successful treatment of the index episode with ECT. We reviewed the charts of patients with affective illnesses who received continuation ECT (C-ECT) in our inpatient service from 1985 to 1991. In 33 courses of C-ECT, mean intertreatment interval was 10.1 days and the average duration of treatment was 10 weeks. One-year follow-up was available for 21 patients. Seven (33%) patients relapsed and needed re-admission within 1 year. The relapse rate for the patients with delusional depression was 42%, lower than the 95% reported for patients with delusional depression maintained on continuation pharmacotherapy before the C-ECT program started in our facility. No single factor examined was a significant predictor of relapse except C-ECT, which exhibited a sustained prophylactic effect for the year after the index episode.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7834255

Source DB:  PubMed          Journal:  Convuls Ther        ISSN: 0749-8055


  6 in total

Review 1.  Pharmacotherapy to sustain the fully remitted state.

Authors:  Sidney Kennedy; Roger McIntyre; Angelo Fallu; Raymond Lam
Journal:  J Psychiatry Neurosci       Date:  2002-07       Impact factor: 6.186

2.  Toward individualized post-electroconvulsive therapy care: piloting the Symptom-Titrated, Algorithm-Based Longitudinal ECT (STABLE) intervention.

Authors:  Sarah H Lisanby; Shirlene Sampson; Mustafa M Husain; Georgios Petrides; Rebecca G Knapp; W Vaughn McCall; Robert C Young; Joan Prudic; Charles H Kellner
Journal:  J ECT       Date:  2008-09       Impact factor: 3.635

Review 3.  Catatonia in autism: implications across the life span.

Authors:  Angelina Kakooza-Mwesige; Lee E Wachtel; Dirk M Dhossche
Journal:  Eur Child Adolesc Psychiatry       Date:  2008-04-21       Impact factor: 4.785

Review 4.  [Electroconvulsive therapy as maintenance therapy and for prevention of recurrence in psychiatric disorders and Parkinson disease].

Authors:  Matthäus Willeit; Nicole Praschak-Rieder; Siegfried Kasper
Journal:  Wien Klin Wochenschr       Date:  2003-05-15       Impact factor: 1.704

5.  Ketamine for depression relapse prevention following electroconvulsive therapy: protocol for a randomised pilot trial (the KEEP-WELL trial).

Authors:  Martha Finnegan; Karen Ryan; Enda Shanahan; Andrew Harkin; Leslie Daly; Declan M McLoughlin
Journal:  Pilot Feasibility Stud       Date:  2016-08-03

6.  Combination of Electroconvulsive Therapy and Clozapine in Treatment-Resistant Schizophrenia.

Authors:  Jung Hyun Kim; Tak Youn; Jun Gwon Choi; Seong Hoon Jeong; Hee Yeon Jung; Yong Sik Kim; In Won Chung
Journal:  Psychiatry Investig       Date:  2018-08-09       Impact factor: 2.505

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.